A nurse is planning to learn about a culture by observing the cultural practices from the outside. The nurse is planning to obtain which of the following types of information?

Choice A reason: Developing a statement about health alterations is part of documentation but not the first action. Stress impacts the hypothalamic-pituitary-adrenal axis, increasing cortisol, and requires assessment first to identify cognitive or emotional changes, ensuring targeted interventions rather than premature documentation of unassessed conditions.

Choice B reason: Conducting a mental status exam first assesses cognitive, emotional, and behavioral changes due to stress, which activates the amygdala and elevates cortisol, impairing prefrontal cortex function. This identifies severity (e.g., anxiety, impaired concentration), guiding appropriate interventions like counseling or relaxation techniques to address physiological and psychological stress effects.

Choice C reason: Establishing goals is important but secondary to assessment. Stress affects neuroendocrine pathways, increasing catecholamines and cortisol, which impair cognition. Without assessing mental status, goals may be misaligned, as understanding the client’s stress-related symptoms is critical to setting realistic, effective short- and long-term objectives.

Choice D reason: Teaching stress-reduction techniques is effective but not the first step. Stress elevates sympathetic activity, increasing heart rate and cortisol. Without assessing mental status, techniques may be inappropriate. A mental status exam identifies specific stress manifestations, ensuring tailored interventions to reduce physiological and psychological stress responses.

Choice A reason: Insulin detemir is a long-acting insulin analog, providing basal coverage over 12-24 hours by binding to albumin, slowing absorption. In diabetic ketoacidosis (DKA), rapid correction of hyperglycemia and acidosis requires short-acting insulin like regular insulin, as detemir’s slow onset cannot address acute metabolic decompensation effectively.

Choice B reason: NPH insulin is an intermediate-acting insulin with an onset of 1-2 hours and duration of 12-18 hours. Its delayed action makes it unsuitable for DKA, where rapid-acting insulin is needed to quickly lower blood glucose and suppress ketogenesis, preventing further acidosis and metabolic deterioration.

Choice C reason: Insulin glargine, a long-acting insulin, provides steady basal coverage over 24 hours with no peak. Its slow, sustained release is inappropriate for DKA, which demands immediate, titratable insulin to rapidly correct hyperglycemia, ketonemia, and acidosis, restoring metabolic balance in an acute emergency setting.

Choice D reason: Regular insulin, a short-acting insulin, has an onset of 30 minutes and duration of 3-6 hours, making it ideal for DKA treatment. Administered intravenously, it rapidly lowers blood glucose, suppresses ketone production, and corrects acidosis by facilitating glucose uptake and inhibiting lipolysis, stabilizing the patient’s metabolic state.